Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide

At 22 weeks post‐transplantation for HBV‐related cirrhosis, an adult woman developed neutropenia which was aggravated by COVID‐19 (ANC 0.4 × 10(9)/L). Covid resolution and all “conventional” modifications were ineffective. Success within 2 weeks was achieved by switching entecavir to tenofovir alafe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, I. Vern, Yurttaş, Nurgül Özgür, Ayer, Mesut, Poturoğlu, Şule, Kınacı, Erdem, Özden, İlgin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421973/
https://www.ncbi.nlm.nih.gov/pubmed/37575459
http://dx.doi.org/10.1002/ccr3.7741
_version_ 1785089095990509568
author Lim, I. Vern
Yurttaş, Nurgül Özgür
Ayer, Mesut
Poturoğlu, Şule
Kınacı, Erdem
Özden, İlgin
author_facet Lim, I. Vern
Yurttaş, Nurgül Özgür
Ayer, Mesut
Poturoğlu, Şule
Kınacı, Erdem
Özden, İlgin
author_sort Lim, I. Vern
collection PubMed
description At 22 weeks post‐transplantation for HBV‐related cirrhosis, an adult woman developed neutropenia which was aggravated by COVID‐19 (ANC 0.4 × 10(9)/L). Covid resolution and all “conventional” modifications were ineffective. Success within 2 weeks was achieved by switching entecavir to tenofovir alafenamide. A step‐by‐step judicious approach to post‐transplant neutropenia is vital.
format Online
Article
Text
id pubmed-10421973
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-104219732023-08-13 Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide Lim, I. Vern Yurttaş, Nurgül Özgür Ayer, Mesut Poturoğlu, Şule Kınacı, Erdem Özden, İlgin Clin Case Rep Case Report At 22 weeks post‐transplantation for HBV‐related cirrhosis, an adult woman developed neutropenia which was aggravated by COVID‐19 (ANC 0.4 × 10(9)/L). Covid resolution and all “conventional” modifications were ineffective. Success within 2 weeks was achieved by switching entecavir to tenofovir alafenamide. A step‐by‐step judicious approach to post‐transplant neutropenia is vital. John Wiley and Sons Inc. 2023-08-11 /pmc/articles/PMC10421973/ /pubmed/37575459 http://dx.doi.org/10.1002/ccr3.7741 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Lim, I. Vern
Yurttaş, Nurgül Özgür
Ayer, Mesut
Poturoğlu, Şule
Kınacı, Erdem
Özden, İlgin
Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide
title Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide
title_full Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide
title_fullStr Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide
title_full_unstemmed Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide
title_short Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide
title_sort entecavir‐induced neutropenia in an adult living donor liver transplant recipient: successful conversion to tenofovir alafenamide
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421973/
https://www.ncbi.nlm.nih.gov/pubmed/37575459
http://dx.doi.org/10.1002/ccr3.7741
work_keys_str_mv AT limivern entecavirinducedneutropeniainanadultlivingdonorlivertransplantrecipientsuccessfulconversiontotenofoviralafenamide
AT yurttasnurgulozgur entecavirinducedneutropeniainanadultlivingdonorlivertransplantrecipientsuccessfulconversiontotenofoviralafenamide
AT ayermesut entecavirinducedneutropeniainanadultlivingdonorlivertransplantrecipientsuccessfulconversiontotenofoviralafenamide
AT poturoglusule entecavirinducedneutropeniainanadultlivingdonorlivertransplantrecipientsuccessfulconversiontotenofoviralafenamide
AT kınacıerdem entecavirinducedneutropeniainanadultlivingdonorlivertransplantrecipientsuccessfulconversiontotenofoviralafenamide
AT ozdenilgin entecavirinducedneutropeniainanadultlivingdonorlivertransplantrecipientsuccessfulconversiontotenofoviralafenamide

Ejemplares similares